Potency evaluation of unfractionated heparins commercialized in Brazil through anti-factor Xa and anti-factor IIa chromogenic tests and coagulation assay: Vigil Sanit Debate, Rio de Janeiro, 2023, v.11: e01923 | Publicado em: 11/05/2023. (2023). Vigilância Sanitária Em Debate , 11, 1-10. https://doi.org/10.22239/2317-269x.01923